Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
iShares Core S&P 500 ETF
IVV
5
Vanguard S&P 500 ETF
VOO
No Data
No Data
No Data
AbbVie's Real-World Study on Upadacitinib for Atopic Dermatitis: Key Insights for Investors
TipRanks00:39
AbbVie's New Study on Ulcerative Colitis: A Potential Game Changer?
TipRanks00:28
AbbVie and Genmab's Epcoritamab Trial: A Potential Game-Changer for B-NHL Treatment
TipRanks00:26
AbbVie's Promising Phase 2 Study on ADPKD Treatment: A Closer Look
TipRanks00:19
AbbVie's Upadacitinib Study: A New Hope for Hidradenitis Suppurativa?
TipRanks00:17
AbbVie's Venetoclax Study Update: Long-Term Safety in Focus
TipRanks00:12
- No more -